Indian Actinomycin Exporters: Complete Supplier Ranking with Market Share — 351 Manufacturers (2026) — TransData Nexus

Q: Who is the largest actinomycin buyer importing from India?

EUGIA US LLC (UNITED STATES) is the largest actinomycin importer from India with a 35.7% market share and import value of $1.0M.

Q: How many actinomycin buyers import from India?

There are 351 active actinomycin buyers importing from India, with a combined import market of $2.9M across 933 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top actinomycin buyers from India?

The top 5 actinomycin buyers — EUGIA US LLC, EUGIA US LLC,, AUROLOGISTIC LLC, ONCOPHARM SPECIALITY PHARMACY, ETHIOPIAN PHARMACEUTICALS — together control 75.3% of total actinomycin import value from India.

Suresh Sormare

Actinomycin

India Pharmaceutical Trade Intelligence

$2.9M184 Suppliers97 CountriesHS 30049046

ExportsIndia → UNITED STATES73.5%India → BRAZIL8.4%

ImportsUNITED STATES → India$114

#1 Supplier: EUGIA PHARMA #1 Buyer: EUGIA US

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $2.2M through 9 shipments. This represents a market share of 73.5% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• EUGIA US LLC - $1.0M (48.6% of country's total business)

• EUGIA US LLC, - $754.4K (35.0% of country's total business)

• AUROLOGISTIC LLC - $348.8K (16.2% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $239.5K, indicating premium pricing strategy compared to the market average of $3.1K.

United States is a key market for Actinomycin imports, representing 73.5% of total trade value.

Primary Market

Secondary Market

2Brazil

Brazil emerges as the second largest importing country, achieving a total trade value of $245.8K through . This represents a market share of of the total market activity, demonstrating their significant presence in the industry.

Buyer Segment Analysis

TransData Nexus Actinomycin buyer market intelligence

1Buyer Segment Analysis

The importers of Actinomycin from India can be categorized into several segments:

1. Distributors: Entities like EUGIA US LLC and AUROLOGISTIC LLC in the United States fall into this category. Distributors typically purchase large volumes to supply hospitals, pharmacies, and other healthcare providers. Their buying behavior is characterized by bulk orders and a focus on maintaining a consistent supply chain to meet market demand.

2. Hospital Groups: Organizations such as ONCOPHARM SPECIALITY PHARMACY in Uganda and ETHIOPIAN PHARMACEUTICALS in Ethiopia represent hospital groups. These buyers procure Actinomycin directly for patient treatment within their facilities. Their order patterns are often based on patient needs and treatment protocols, leading to variable purchasing volumes.

3. Government Procurement Agencies: Entities like the Ministry of Health in Ethiopia and the National Medical Stores in Uganda engage in centralized procurement for public healthcare institutions. Their purchasing behavior involves large-scale tenders and contracts to ensure the availability of essential medicines across the public health sector.

4. Re-exporters: Companies such as TO THE and EXP CODE in Brazil may act as re-exporters, purchasing Actinomycin for distribution to neighboring countries. Their buying patterns are influenced by regional demand and trade agreements, often resulting in fluctuating order sizes.

5. Contract Manufacturers: Some buyers may engage in contract manufacturing, sourcing Actinomycin as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their procurement is typically aligned with production schedules and market demand forecasts.

Country-Specific Import Regulations

TransData Nexus Actinomycin buyer market intelligence

1Country-Specific Import Regulations

United States

1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).

2. Import Registration Process for Actinomycin: Importers must ensure that Actinomycin is approved by the FDA. The process involves submitting a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) for generic versions. Additionally, facilities manufacturing the drug must be registered with the FDA and comply with Good Manufacturing Practices (GMP).

3. Estimated Timeline for Registration: The FDA review process for NDAs typically takes 10 months, while ANDAs may take 8 to 10 months.

4. Import Tariff/Duty for HS 30049046: Pharmaceutical products under HS code 30049046 are generally duty-free in the United States.

Brazil

1. Drug Regulatory Authority: Agência Nacional de Vigilância Sanitária (ANVISA).

2. Import Registration Process for Actinomycin: Importers must obtain a sanitary license from ANVISA, register the product, and ensure compliance with Brazilian pharmacopoeia standards. The process includes dossier submission, technical evaluation, and GMP certification of the manufacturing facility.

3. Estimated Timeline for Registration: The registration process can take approximately 6 to 12 months, depending on the completeness of the application and ANVISA's workload.

4. Import Tariff/Duty for HS 30049046: Pharmaceutical products under this HS code are subject to an import duty of 8% in Brazil.

Uganda

1. Drug Regulatory Authority: National Drug Authority (NDA).

2. Import Registration Process for Actinomycin: Importers must submit an application to the NDA, including product dossiers, GMP certificates, and samples. The NDA conducts evaluations to ensure safety, efficacy, and quality.

Demand Drivers & Market Opportunity

TransData Nexus Actinomycin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Actinomycin in importing countries is primarily driven by its critical role in treating various cancers, including Wilms' tumor, rhabdomyosarcoma, and gestational trophoblastic neoplasia. The inclusion of Actinomycin on the WHO Model List of Essential Medicines underscores its importance in oncology treatment protocols. (who.int)

Government healthcare programs and the expansion of universal health coverage have significantly increased access to essential medicines. For instance, the WHO's efforts to improve global access to essential medicines have led to the regular updating of the WHO Model Lists of Essential Medicines and providing technical support to member states. (who.int) Additionally, tender-based purchasing mechanisms, as recommended by the WHO, have been implemented to ensure the availability and affordability of essential medicines like Actinomycin.

Our data indicates that Actinomycin has been exported to 97 countries, with 351 buyers recorded. The repeat buyer rate of 28.8% suggests a stable demand, likely due to ongoing treatment needs and the drug's established efficacy. This consistent demand presents a substantial market opportunity for suppliers, especially in countries with expanding healthcare infrastructures and commitments to universal health coverage.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Actinomycin Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest actinomycin buyer importing from India?

Based on import volume and value, EUGIA US LLC (UNITED STATES) leads with $1.0M in imports and a 35.7% market share — the highest of any single actinomycin importer. EUGIA US LLC, (UNITED STATES) and AUROLOGISTIC LLC (UNITED STATES) are the next largest buyers.

QHow many companies buy actinomycin from India?

There are 351 active actinomycin buyers importing from India, with a combined market of $2.9M across 933 shipments to 97 countries. The top 5 buyers hold 75.3% of total import value, while the remaining 346 buyers handle the other 24.7%.

QWhich countries import the most actinomycin from India?

The top importing countries for actinomycin from India are United States (73.5%), Brazil (8.4%), Uganda (1.3%), Ethiopia (1.2%), United Arab Emirates (1.1%). These markets represent the largest demand centres for Indian pharmaceutical exports of actinomycin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for actinomycin from India?

The average import transaction value for actinomycin from India is $3.1K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Actinomycin buyer market intelligence

1Buyer Segment Analysis

The importers of Actinomycin from India can be categorized into several segments:

Country-Specific Import Regulations

TransData Nexus Actinomycin buyer market intelligence

1Country-Specific Import Regulations

United States

1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).

3. Estimated Timeline for Registration: The FDA review process for NDAs typically takes 10 months, while ANDAs may take 8 to 10 months.

4. Import Tariff/Duty for HS 30049046: Pharmaceutical products under HS code 30049046 are generally duty-free in the United States.

Brazil

1. Drug Regulatory Authority: Agência Nacional de Vigilância Sanitária (ANVISA).

3. Estimated Timeline for Registration: The registration process can take approximately 6 to 12 months, depending on the completeness of the application and ANVISA's workload.

4. Import Tariff/Duty for HS 30049046: Pharmaceutical products under this HS code are subject to an import duty of 8% in Brazil.

Uganda

1. Drug Regulatory Authority: National Drug Authority (NDA).

Demand Drivers & Market Opportunity

TransData Nexus Actinomycin buyer market intelligence

1Demand Drivers & Market Opportunity

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Actinomycin

Actinomycin

Who Buys Actinomycin from India — 351 Importers Behind a $2.9M Market

Top Actinomycin Importers — Ranked by Import Value

Top Actinomycin Buyers & Importers

Related Analysis

Need Details?

Actinomycin — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Actinomycin — and from which countries?

Actinomycin — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

2Brazil

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Actinomycin Buyers & Importers

QWho is the largest actinomycin buyer importing from India?

QHow many companies buy actinomycin from India?

QWhich countries import the most actinomycin from India?

QWhat is the average import order value for actinomycin from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Uganda

4Ethiopia

5United Arab Emirates

Analysis Methodology